换一批Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation.
第一作者：
S,Leyvraz
第一单位：
Centre Pluridisciplinaire d'Oncologie, Lausanne, Switzerland. serge.leyvraz@chuv.hospvd.ch
作者：
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 小细胞(Carcinoma, Small Cell);顺铂(Cisplatin);剂量效应关系, 药物(Dose-Response Relationship, Drug);依托泊甙(Etoposide);欧洲(Europe);可行性研究(Feasibility Studies);女(雌)性(Female);非格司亭(Filgrastim);粒细胞集落刺激因子(Granulocyte Colony-Stimulating Factor);造血干细胞(Hematopoietic Stem Cells);人类(Humans);异环磷酰胺(Ifosfamide);Logistic模型(Logistic Models);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);重组蛋白质类(Recombinant Proteins)
DOI
10.1200/JCO.1999.17.11.3531
PMID
10550151
发布时间
2017-02-10
- 浏览111
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
